Skip to content

Randomized, double-blind, placebo-controlled study to compare the Efficacy of Combination of Lidocaine with Ketorolac or Triamcinolone versus Lidocaine alone for Soft Tissue Injuries Pain Management

Randomized, double-blind, placebo-controlled study to compare the Efficacy of Combination of Lidocaine with Ketorolac or Triamcinolone versus Lidocaine alone for Soft Tissue Injuries Pain Management

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20161220002
Enrollment
Unknown
Registered
2016-12-20
Start date
2016-12-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammation of soft tissue and efficacy of local ketorolac injection efficacy of local injection ketorolac

Interventions

ketorolac 30 mg + 2% lidocaine 2 cc.,ketorolac 60 mg + 2% lidocaine 2 cc.,triamcinolone 10 mg + 2% lidocaine 2 cc,triamcinolone 20 mg + 2% lidocaine 2 cc,0.9% NSS 1&#45
2 cc.+ 2% lidocaine 2 cc.,triamcinolone 40 mg + 2% lidocaine 2 cc
ketorolac 30mg,ketorolac 60 mg,triamcinolone 10 mg,triamcinolone 20 mg,0.9% NSS 1&#45
2 cc.,triamcinolone 40 mg

Sponsors

NRCT
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.age above 18 years old 2. signed inform and consent 3. diagnosis as inflammation of soft tissue

Exclusion criteria

Exclusion criteria: 1.pain less than 50 in VAS 2.have NSAIDs before study less than 48 hrs 3.on probenecid,furosemide and MTX 4.infection of soft tissue and joint 5.fracture of bone 6.plan for surgery in 1 week 7.history of acute renal failure 8. age more than 65 years old 9. glaucoma 10.allergy to NSAIDs 11.peptic ulcer 12.pregnancy 13.history of diabetic 14.on anticoagulant

Design outcomes

Primary

MeasureTime frame
pain score after administration ketorolac,triamcinolone,placebo 10 min VAS score

Secondary

MeasureTime frame
pain score after administration ketorolac,triamcinolone,placebo 30 mins 1 hr 2 hr 6 hr 24 hr VAS score,time to activity return after administration ketorolac,triamcinolone,placebo 30s min able/unable,satisfaction after administration between ketorolac,triamcinolone,placebo 2 hrs 24 hrs safisfaction score,side effect after administration between ketorolac,triamcinolone,placebo 1 wk side effec

Countries

thailand

Contacts

Public Contactbura sindhupakorn

SUT

bura@sut.ac.th0805886686

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026